Investor Stock List
Ranked #3,763 of 8,699 institutional investors

Artia Global Partners LP

Miami, FL

$471M
US stock portfolio at live prices · today −$3.9M (−0.83%)
Live prices, last trade 10:40 AM ET
Value at quarter end (Q3 2026)
$492M
Change from Q2 2026
−$34.2M (−6.51%)
Positions
44 · 12 new, 8 sold out
Filed
Nov 16, 2026

Not counted in the ranking: put options on $3.9M. $57.3M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
INSM 18.4%BTSG 8.25%RVMD 6.56%TRVI 6.36%ARGX 5.93%
StockSharesValue, live% of portfoliovs Q2 2026
INSM Insmed Incorporated589,052$86.6M18.4%Unchanged
BTSG BrightSpring Health Services, Inc.609,944$38.8M8.25%Added +18%
RVMD Revolution Medicines, Inc.185,390$30.9M6.56%Unchanged
TRVI Trevi Therapeutics, Inc.2,210,852$30.0M6.36%Unchanged
ARGX argenx SE29,739$27.9M5.93%Unchanged
ABVX ABIVAX Société Anonyme364,268$24.7M5.24%Reduced −29%
TVTX Travere Therapeutics, Inc.398,493$19.4M4.12%Added +18%
DGX Quest Diagnostics Incorporated65,122$16.9M3.60%Unchanged
GH Guardant Health, Inc.96,704$14.0M2.97%Added +154%
DNTH Dianthus Therapeutics, Inc.165,735$13.9M2.96%Added +2%
RVTY Revvity, Inc.80,948$11.9M2.53%New
MRK Merck & Co., Inc.80,500$10.9M2.32%Added +72%
JNJ Johnson & Johnson27,100$7.4M1.56%Added +20%
BIIB Biogen Inc.29,237$7.3M1.56%Added +59%
EWTX Edgewise Therapeutics, Inc.161,175$6.6M1.40%Added +63%
BRKR Bruker Corporation103,796$6.1M1.30%New
TMO Thermo Fisher Scientific Inc.7,610$5.2M1.10%New
SRRK Scholar Rock Holding Corporation96,285$5.0M1.05%Unchanged
VKTX Viking Therapeutics, Inc.180,731$4.6M0.98%Unchanged
RAPP Rapport Therapeutics, Inc.166,508$3.9M0.84%Added +20%
CYTK Cytokinetics, Incorporated70,700$3.7M0.80%Unchanged
ABSI Absci Corporation464,444$3.6M0.76%Unchanged
ELVN Enliven Therapeutics, Inc.72,100$3.4M0.72%Unchanged
BLTE Belite Bio, Inc24,989$3.3M0.70%Unchanged
ORKA Oruka Therapeutics, Inc.33,400$3.2M0.68%Unchanged
CELC Celcuity Inc.50,522$2.8M0.59%Reduced −15%
PTGX Protagonist Therapeutics, Inc.22,951$2.8M0.59%Unchanged
UTHR United Therapeutics Corporation5,000$2.8M0.59%Unchanged
GRAL GRAIL, Inc.25,200$2.6M0.54%New
TXG 10x Genomics, Inc.46,300$2.5M0.53%New
MLYS Mineralys Therapeutics, Inc.137,800$1.9M0.41%Unchanged
TWST Twist Bioscience Corporation15,300$1.6M0.34%New
CORT Corcept Therapeutics Incorporated18,000$1.2M0.25%New
A Agilent Technologies, Inc.5,800$1.0M0.21%New
RXRX Recursion Pharmaceuticals, Inc.334,402$884K0.19%New
DRUG Bright Minds Biosciences Inc.38,407$808K0.17%Unchanged
PEPG PepGen Inc.205,324$784K0.17%Unchanged
PRAX Praxis Precision Medicines, Inc.2,500$768K0.16%Unchanged
PROK ProKidney Corp.553,744$576K0.12%Reduced −69%
MBX MBX Biosciences, Inc.8,300$435K<0.1%New
SYRE Spyre Therapeutics, Inc.4,000$386K<0.1%Unchanged
CLYM Climb Bio Inc21,097$193K<0.1%New
DNA Ginkgo Bioworks Holdings, Inc.20,444$162K<0.1%New
EYPT EyePoint, Inc.464,698$119K<0.1%Reduced −39%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
IONS Ionis Pharmaceuticals, Inc.144,376$4.0M
XENE Xenon Pharmaceuticals Inc.65,000$2.4M
PALI Palisade Bio, Inc.1,992,367$1.9M
KOD Kodiak Sciences Inc.17,019$1.7M
ALMS Alumis Inc.278,546$1.2M
SION Sionna Therapeutics, Inc.119,741$350K
CMPX Compass Therapeutics, Inc.383,200$272K
TENX Tenax Therapeutics, Inc.42,080$56K